10X Genomics Inc vs Teucrium Wheat Fund — how do they compare? 10X Genomics Inc trades at $67.62 (market cap $8.55B), while Teucrium Wheat Fund trades at $26.26. The key difference: 10X Genomics Inc is trading nearer its 52-week high, Teucrium Wheat Fund nearer its low. Which is the better fit depends on your goals.
| TXG | WEAT | |
|---|---|---|
Market Cap | $8.55B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $67.29 | $28.00 |
52-Week Low | $11.34 | $19.88 |
Enterprise Value | $8.08B | — |
Signals from Pluang's Aura AI — not financial advice
TXG trades at $65.60, up 4.71% today, with strong technical momentum showing bullish moving averages and key support at $63. Fundamentally, the company demonstrates improving trends with Q2 2026 earnings beating estimates and revenue growth guidance raised, though profitability remains negative with a -12.18% net margin. Recent patent victory against Parse Biosciences strengthens competitive positioning.
The outlook remains cautiously optimistic with analyst consensus at 45% buy ratings and $50.78 price target. Key opportunities include Atera platform adoption and consumables growth, while risks center on valuation premiums and ongoing profitability challenges. The stock trades near resistance at $67 with institutional interest showing mixed signals.
WEAT, a US-listed wheat ETF, trades at $26.96, up 1.77% today, with a bullish technical signal from moving averages and ADX indicating strong trend momentum. Recent performance shows a 9.9% gain over the past month, driven by inflation concerns and commodity strength. Key support and resistance cluster around $27, suggesting a pivotal price zone.
Outlook remains positive due to inflation hedging demand, but risks include commodity price volatility and Federal Reserve policy shifts. The ETF lacks traditional fundamental metrics like P/E or revenue, relying on wheat futures performance. Investors should weigh macroeconomic trends against potential pullbacks in agricultural markets.
Trailing returns across standard periods
Latest headlines on both assets
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →